Article
Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study.
Lancet (London, England) - 2 Mar 2002
Quéré Isabelle, Perneger Thomas V, Zittoun Jacqueline, Bellet Hélène, Gris Jean-Christophe, Daurès Jean-Pierre, Schved Jean-François, Mercier Eric, Laroche Jean-Pierre, Dauzat Michel, Bounameaux Henri, Janbon Charles, de Moerloose Philippe
Abstract excerpt
BACKGROUND: Moderate hyperhomocysteinaemia is a risk factor for venous thromboembolism. We do not know whether this risk depends on homocysteine itself or on components of the homocysteine remethylation pathway, such as methylfolate. We did a case-control study to analyse the relation between the major components of the homocysteine remethylation pathway and risk of venous thromboembolism. METHODS: We measured...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
